Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction

20061,035 citationsJournal Article

Authors

Birgit Aßmus

Jörg Honold

Volker Schächinger

Martina Britten

Ulrich Fischer‐Rasokat

Nasreddin Abolmaali · Goethe University Frankfurt

Torsten Tonn · Institute for Transfusion Medicine

Abstract

Intracoronary infusion of progenitor cells is safe and feasible in patients with healed myocardial infarction. Transplantation of BMC is associated with moderate but significant improvement in the left ventricular ejection fraction after 3 months.

Topics & Keywords

Mesenchymal stem cell research Cardiac and Coronary Surgery Techniques Mechanical Circulatory Support Devices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 355, Issue 12, pp. 1222-1232

DOI: 10.1056/nejmoa051779

Field-Weighted Citation Impact: 62.95